Purpose and Structure
This guide serves as a last-minute revision tool for the USMLE Step 1 exam, synthesizing high-yield information from
credible sources.
It focuses on frequently tested concepts, common pitfalls, and effective memory aids to maximize exam scores.
The structure is designed for rapid review and deep understanding, emphasizing active learning over rote
memorization.
How to Use This Guide
Quick Facts: Summarizes essential information in concise bullet points for quick reference.
High-Yield Concepts: Highlights key principles and facts for immediate recognition during study sessions.
Recent Test-Taker Insights: Provides feedback from recent examinees on frequently tested topics and question styles.
Common Exam Traps: Identifies common pitfalls and misconceptions to avoid during the exam.
Comparison Tables: Organizes data visually for easy differentiation of similar conditions or concepts.
Clinical Correlations: Connects basic science with clinical medicine through real-world applications.
Foundational Sciences
Biochemistry Overview
Biochemistry is the study of chemical processes within and relating to living organisms, crucial for understanding
metabolic pathways.
It encompasses various metabolic processes including carbohydrate, lipid, and protein metabolism, each with specific
pathways and regulatory mechanisms.
Molecular Biology: The Central Dogma
, Central Dogma: Describes the flow of genetic information from DNA to RNA to protein, essential for understanding
gene expression.
Key Processes: Includes replication, transcription, and translation, each with specific enzymes and regulatory
mechanisms.
Gene Regulation: Involves operons in prokaryotes and transcription factors in eukaryotes, crucial for understanding
gene expression control.
Carbohydrate Metabolism
Glycolysis: Converts glucose to pyruvate, yielding energy; regulated by key enzymes like hexokinase and pyruvate
kinase.
Gluconeogenesis: Synthesizes glucose from non-carbohydrate sources, primarily in the liver; involves key enzymes
like pyruvate carboxylase.
Glycogen Metabolism: Involves glycogenesis and glycogenolysis, regulated by glycogen synthase and phosphorylase,
respectively.
Lipid Metabolism
Fatty Acid Synthesis: Occurs in the cytoplasm, using Acetyl-CoA and NADPH; key enzyme is fatty acid synthase.
Beta-Oxidation: Breaks down fatty acids into acetyl-CoA in mitochondria; requires carnitine for long-chain fatty acids
transport.
Clinical Correlations: Includes conditions like carnitine deficiency and familial hypercholesterolemia, highlighting the
importance of lipid metabolism.
Clinical Correlations and Mnemonics
Clinical Correlations in Biochemistry
Chemotherapeutic Agents: Target DNA replication to inhibit cancer cell proliferation, particularly during the S-phase.
Rifampin: Inhibits bacterial RNA polymerase, used in tuberculosis treatment, illustrating the application of molecular
biology in medicine.
, Glycogen Storage Diseases (GSDs): Defects in glycogen metabolism, such as Von Gierke and McArdle diseases,
with clinical presentations and management strategies.
Mnemonics and Memory Aids
DNA Replication: "Some Drugs Affect Replication" (S-phase, DNA polymerase, Antiparallel, Replication) for
remembering key concepts.
Lac Operon: "Lack of Lactose Represses Operon" to recall the regulation of the lac operon.
G6PD Deficiency: "Guys 6 People Don't Drink Fava Beans" to remember triggers for hemolytic anemia in G6PD
deficiency.
Clinical Correlations in Lipid Metabolism
Key Disorders and Conditions
Carnitine Deficiency: Impairs long-chain fatty acid transport, leading to hypoglycemia and muscle weakness. This
condition highlights the importance of carnitine in fatty acid metabolism and energy production.
Statins: These drugs inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, leading to lower cholesterol
levels and increased LDL receptors on liver cells, enhancing cholesterol clearance from the bloodstream.
Familial Hypercholesterolemia: A genetic disorder characterized by defective LDL receptors, resulting in very high
levels of LDL cholesterol and increased risk of cardiovascular disease.
Type I Hyperlipoproteinemia (Familial LPL Deficiency): Caused by a deficiency of lipoprotein lipase (LPL) or ApoC-
II, leading to very high levels of chylomicrons and triglycerides in the blood, which can cause pancreatitis.
Mechanisms and Management
Differentiation of Lipoproteins: Understanding the functions and compositions of major lipoproteins (e.g., LDL, HDL)
is crucial for lipid management and cardiovascular risk assessment.
Statins Mechanism of Action: Statins lower cholesterol levels by inhibiting HMG-CoA reductase, which decreases
cholesterol synthesis and increases the number of LDL receptors, thus enhancing the clearance of LDL from the
bloodstream.